Header Logo

Connection

MATTHEW CAMPBELL to Palivizumab

Back to Details
This is a "connection" page, showing publications MATTHEW CAMPBELL has written about Palivizumab.
MATTHEW CAMPBELL
Connection Strength
0.208
Palivizumab
  1. Improvement in Palivizumab Administration Prior to Discharge for Hospitalized Infants with Hemodynamically Significant Congenital Heart Disease: A Quality Improvement Initiative. Pediatr Cardiol. 2024 Oct; 45(7):1415-1423.
    View in: PubMed
    Score: 0.208
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.